Loading insider details...
Latest Form 4 (Oct 22, 2026): Grant/Award of 18,200 MBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 22, 2026 | MBX Biosciences, Inc. (MBX) | Grant/Award | 18,200 | n/a |
| Jun 8, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 16,988 | $326.0K |
| Mar 17, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 7,220 | n/a |
| Mar 11, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 5,912 | $93.8K |
| Feb 4, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale | 2,631 | $271.8K |
| Jan 30, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 25,120 | n/a |
| Jan 27, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 5,750 | n/a |
| Jan 23, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 4,167 | n/a |
| Mar 19, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 14,440 | n/a |
| Mar 5, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale | 13,681 | $623.5K |